On July 1st, 2015 a new online form for Australia’s clinical trial notification (CTN) scheme was made available. According to the TGA site, these notifications apply to the clinical trial or use of a product in Australia which is:

  • not on the Australian Register of Therapeutic Goods
  • on the ARTG but being used outside the conditions of its marketing approval

Over 95% of trials are approved through the CTN. The TGA site states that this online form is a first step of many developments towards a better administrative process of these clinical trial schemes.

In wake of this new online form, the original paper version, which makes for a longer administrative process, will no longer be accepted.

The TGA notes many benefits of the new online form such as the ability to manage and track notifications through a personal online dashboard and make amendments to any clinical information directly and more efficiently.

Any paper versions of this form which have been submitted past July 1st will also need to be submitted online. The TGA is willing to work with affected clinical trial sponsors through this initial transition period.
Guidance material for the new CTN form is available on the TGA website.

RegDesk is an A.I.-powered regulatory intelligence software that offers 24/7 access to the latest regulatory information for over 50 markets worldwide. Our platform eliminates the need for medical device companies to spend months gathering intelligence and preparing their registration applications. Through RegDesk’s centralized platform, clients can get access to product-specific registration requirements, expert answers to their most critical regulatory questions, and real-time alerts about global regulatory changes. To experience the power of RegDesk, contact us at desk@regdesk.co or visit www.regdesk.co.